Manufacturers

Torrent Pharmaceuticals Ltd

Salt Composition

Levodopa (100mg) + Carbidopa (25mg) + Entacapone (200mg)

Medicine Type

drugs

Introduction

In Parkinson's disease Tidomet E 100mg/25mg/200mg Tablet is a medicine that helps relieve symptoms of Parkinson's disease such as tremors, muscle stiffness and difficulty moving. It increases the amount of a chemical called dopamine in the brain which helps in coordination of body movements. This medicine can therefore enhance the quality of life by improving the ability to carry out daily functions in a better manner.

Benefits

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tidomet E 100mg/25mg/200mg Tablet may be taken with or without food, but it is better to take it at a fixed time.u003cbr>Avoid Tidomet E 100mg/25mg/200mg Tablet with high protein meals such as cottage cheese, Swiss cheese, protein powder, eggs and milk.

Description

Tidomet E 100mg/25mg/200mg Tablet is a prescription medicine used in the treatment of Parkinson's disease. This medicine helps to reduce excessive shaking by slowing down the body movements. It works by increasing the amount of chemical messenger that is needed to control abnormal movements.Tidomet E 100mg/25mg/200mg Tablet is taken with or without food, but better to avoid high protein meal and dairy products. However, it is advised to take it at the same time each day as this helps to maintain a consistent level of medicine in the body. Take this medicine in the dose and duration advised by your doctor and if you have missed a dose, take it as soon as you remember. You should never skip any doses and try to finish the full course of treatment even if you feel better. It is important that this medication is not stopped suddenly without talking to the doctor as it can result in harmful effects.This medicine may cause side effects like nausea, vomiting, constipation, discoloration of urine, and dryness in the mouth. It causes a sudden onset of dizziness and sleepiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you.  It is common to have diarrhea with this medicine, so drink plenty of fluids and watch for weight loss.Take caution while taking medicine if you are suffering from liver or kidney disease. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.

How To Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tidomet E 100mg/25mg/200mg Tablet may be taken with or without food, but it is better to take it at a fixed time.u003cbr>Avoid Tidomet E 100mg/25mg/200mg Tablet with high protein meals such as cottage cheese, Swiss cheese, protein powder, eggs and milk.

Safety Advise

- Alcohol : UNSAFE

It is unsafe to consume alcohol with Tidomet E 100mg/25mg/200mg Tablet. | - Pregnancy : CONSULT YOUR DOCTOR

Tidomet E 100mg/25mg/200mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. | - Breast feeding : CONSULT YOUR DOCTOR

Tidomet E 100mg/25mg/200mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. | - Driving : UNSAFE

Tidomet E 100mg/25mg/200mg Tablet may cause side effects which could affect your ability to drive.Caution is advised when driving or operating machinery. | - Kidney : SAFE IF PRESCRIBED

Tidomet E 100mg/25mg/200mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Tidomet E 100mg/25mg/200mg Tablet may not be needed in these patients. Please consult your doctor. | - Liver : CAUTION

Tidomet E 100mg/25mg/200mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Tidomet E 100mg/25mg/200mg Tablet may be needed. Please consult your doctor.

If Miss

If you miss a dose of Tidomet E 100mg/25mg/200mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Packaging Detail

strip of 10 tablets

Package

Strip

Qty

10

Product Form

Tablet

Prescription Required

Prescription Required

Fact Box

Habit Forming :: No|Therapeutic Class :: NEURO CNS

Primary Use

Parkinson's disease

Storage

Store below 30°C

Use Of

Parkinson's disease

Common Side Effect

Urine discoloration | Headache | Dryness in mouth | Insomnia (difficulty in sleeping) | Anxiety | Dizziness | Abnormal dreams | Involuntary muscle movement | Gastrointestinal disturbance

Alcoholinteraction

UNSAFE

Pregnancyinteraction

CONSULT YOUR DOCTOR

Lactationinteraction

CONSULT YOUR DOCTOR

Drivinginteraction

UNSAFE

Kidneyinteraction

SAFE IF PRESCRIBED

Liverinteraction

CAUTION

Manufacturer Address

Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

How It Works

Tidomet E 100mg/25mg/200mg Tablet is a combination of three medicines: Levodopa, Carbidopa and Entacapone which treat Parkinsonism. Levodopa is a Carbidopa precursor which gets converted to dopamine, a chemical messenger that controls movement in the brain. Carbidopa is a peripheral decarboxylase inhibitor which prevents the breakdown of Levodopa allowing it to enter the brain and increase dopamine levels. Entacapone is COMT inhibitor which causes higher and more sustained levels of levodopa in blood, leading to greater relief from the symptoms of Parkinson’s disease.

Marketer Details

Torrent Pharmaceuticals Ltd | Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Reference

European Medicine Agency. Levodopa+Carbidopa+Entacapone Sandoz; 2014. [Accessed 23 Apr. 2019] (online) Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/corbilta | Levodopa+Carbidopa+Entacapone. Espoo, Finland: Orion Corporation; 2010. [Accessed 23 Apr. 2019] (online) Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021485s20lbl.pdf